Liquid Crystal Substrates for Label-Free Cell and Protease Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying cancer metastasis and cell migration are hindered by the need for extrinsic cell labeling, which increases complexity and cost, and fail to accurately quantify proteases without distinguishing between their activation states or discriminate between proteases and their inhibitors.
Innovation Solution
The development of liquid crystal assays and biophotonic devices that allow for the detection and quantification of cells, proteases, and protease inhibitors on a substrate without extrinsic labeling, using controlled release matrices and extracellular matrix components, enabling the assessment of cell adhesion, proliferation, and migration in response to chemotactic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If extrinsic cell labeling techniques are used to observe cellular responses, then cell detection and quantification can be achieved, but the expense and complexity of the assay methods increase and highly skilled technicians are required
Solution Approach 1:
The patent employs intrinsic cellular properties (endogenous fluorescence, light scattering, absorption) to enable cell detection and quantification without requiring extrinsic labeling. The assay system uses the cells' own optical characteristics to generate detectable signals, eliminating the need for additional labeling reagents and complex preparation procedures while maintaining measurement precision
Solution Approach 2:
The invention extracts and utilizes the inherent optical properties of cells (fluorescence, light scattering, absorption) as the detection mechanism. By taking out the labeling step entirely and relying on intrinsic cellular characteristics, the assay complexity is reduced while preserving the ability to detect and quantify cellular responses
2Measurement precision
If conventional assay methods are used to measure protease activity, then protease quantification can be achieved, but the methods cannot distinguish between different activation states of proteases or discriminate between proteases and their inhibitors
Solution Approach 1:
The patent applies different substrate types (fluorogenic, chromogenic, radiogenic) to different assay regions or conditions to specifically detect different protease activation states. Each substrate type provides localized information about specific protease forms, enabling discrimination between active, inactive, and inhibited states while maintaining overall protease quantification capability
Solution Approach 2:
The invention uses specialized substrates as intermediaries that selectively react with different protease activation states. These substrate intermediaries convert the biochemical state of proteases into distinguishable optical signals, allowing the detection system to differentiate between various protease forms and their inhibitors without direct observation
3Productivity
If multiple discrete assay regions are integrated into a single substrate, then multiple parameters can be measured simultaneously, but the substrate fabrication complexity increases
Solution Approach 1:
The patent divides the substrate into multiple discrete assay regions, each optimized for specific measurements (cell attachment, proliferation, migration, protease activity). This segmentation allows simultaneous measurement of multiple parameters across different regions while maintaining relatively simple fabrication by using standardized manufacturing processes for each region type
Solution Approach 2:
The invention creates a universal substrate platform that can perform multiple assay functions (cell culture, optical detection, protease measurement) within a single device. The substrate is designed with regions that can accommodate different cell types and assay conditions while using common fabrication techniques, reducing overall manufacturing complexity despite the multi-functional capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These assays provide a robust and efficient means to quantify cell number, adhesion, proliferation, and migration, while distinguishing between protease forms, offering insights into cancer metastasis and cell behavior without the need for costly labeling techniques.
Implementation Method 1
The present invention relates to the fields of molecular biology, cellular biology, developmental biology, stem cell differentiation, immunology, oncology, general laboratory sciences and microbiology, and in particular to methods and compositions based on liquid crystal assays and other biophotonically based assays
Implementation Method 2
methods and compositions based on liquid crystal assays and other biophotonically based assays for detecting and quantifying the number of cells present on a test surface or within a test substrate
Data Source
AI summary
The present invention relates to the field of molecular diagnostics. In particular, the present invention provided improved substrates and methods of using liquid crystals and other biophotonically based assays for quantitating the amount of an analyte in a sample. The present invention also provides materials and methods for detecting non-specific binding of an analyte to a substrate by using a liquid crystal or other biophotonically based assay formats.